Global blood plasma market size and share is currently valued at USD 27,861.25 million in 2022 and is anticipated to generate an estimated revenue of USD 54,787.67 million by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 7.2% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2023 - 2032
Blood plasma is a yellowish liquid component of blood, which contains water, proteins, electrolytes, hormones, and waste products. It plays an essential role in clotting, immune responses, and transportation of nutrients. Plasma-derived products are critical in treating conditions such as hemophilia, immune deficiencies, and burns, as well as for plasma fractionation.
Market Segmentation
The Blood Plasma Market can be segmented based on type, application, end-user, and region.
- By Type
- Fresh Frozen Plasma (FFP)
- Fresh frozen plasma is the component of blood plasma used for transfusion and is primarily used in treating patients with clotting disorders. FFP is a major product within the blood plasma market, as it contains clotting factors, proteins, and immunoglobulins necessary for therapeutic treatments.
- Immunoglobulin
- Immunoglobulins are plasma-derived proteins essential for treating immune deficiency disorders. These include intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG), which are crucial for treating patients with immune system disorders and autoimmune diseases.
- Albumin
- Albumin is one of the most abundant proteins found in blood plasma and is widely used in medical treatments, particularly for burns, liver failure, and critical care situations. It is also increasingly used in drug delivery systems.
- Coagulation Factors
- Coagulation factors, such as Factor VIII and Factor IX, are essential for treating hemophilia and other bleeding disorders. The demand for these plasma-derived products is significant, especially in regions with high hemophilia prevalence.
- Other Plasma Derivatives
- Other plasma derivatives include clotting factor concentrates, alpha-1 antitrypsin, and others used in specialized treatments.
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/global-blood-plasma-market
- By Application
- Hemophilia
- Hemophilia is one of the largest therapeutic segments within the blood plasma market. Plasma-derived products like Factor VIII and Factor IX are essential in treating this bleeding disorder, which requires frequent intravenous infusions of clotting factors.
- Immunodeficiency Disorders
- Immunodeficiency disorders, such as primary immunodeficiency, require the use of immunoglobulin therapies to bolster the immune system. This market segment continues to grow with the rising diagnosis and awareness of immunodeficiency diseases.
- Burns and Trauma
- Plasma products, particularly albumin, are widely used in burn treatment and trauma care to restore plasma volume and support recovery. The increasing incidence of burns and trauma injuries is driving this segment of the market.
- Other Applications
- Plasma derivatives are also used in treatments for liver disease, kidney dialysis, and other medical conditions that require the use of plasma proteins.
- By End-User
- Hospitals
- Hospitals are the largest end-users of plasma-derived therapies, with significant demand for immunoglobulin products and coagulation factors. The hospital sector includes large medical centers, trauma units, and burn treatment facilities, all of which require blood plasma for their specialized treatments.
- Plasma Collection Centers
- Plasma collection centers, where plasma is collected and processed, play an integral role in the supply chain of plasma-derived therapies. These centers serve as a source of blood plasma for further processing into therapeutic products.
- Research and Diagnostics
- Research institutions and diagnostic laboratories use blood plasma to develop and refine new therapies. Research into plasma’s role in disease management and the development of novel medical treatments is fueling market growth.
- By Region
- North America North America dominates the Blood Plasma Market, accounting for the largest market share. The U.S. is home to several large plasma collection centers, which contribute to the country's substantial production and use of plasma-derived products. The rising prevalence of chronic diseases, the high demand for immunoglobulin products, and the growing healthcare infrastructure are key drivers in the region.
- Europe Europe holds the second-largest market share in the blood plasma industry. Countries like Germany, France, and the UK have well-established healthcare systems and an increasing need for plasma-derived therapies. The European Union’s emphasis on sustainable blood plasma collection and the growing number of plasma fractionation centers contribute to the market's expansion.
- Asia-Pacific The Asia-Pacific region is experiencing rapid market growth due to increasing healthcare expenditures and rising demand for blood plasma-based therapies. Countries like China, India, and Japan are witnessing a rise in the diagnosis of immunodeficiency and hemophilia, driving demand for plasma-derived products in these markets.
- Latin America Latin America is also showing potential for growth in the blood plasma market. The region is seeing increasing awareness of plasma-derived therapies and the development of plasma collection centers. However, challenges such as limited healthcare access in certain regions may restrict the growth of the market.
- Middle East & Africa The Middle East & Africa region is witnessing moderate growth in the market, with increasing healthcare investments and efforts to expand the plasma collection infrastructure. However, the market is still in the early stages of adoption, and challenges such as political instability in certain countries may hinder its full potential.
Key Companies in the Blood Plasma Market
Several key players dominate the Blood Plasma Market, focusing on expanding their production capabilities, improving plasma collection, and developing new therapies. Leading companies include:
- Grifols
Grifols is a global leader in the production of plasma-derived medicines and has a robust portfolio of immunoglobulin products, albumin, and coagulation factors. With a strong presence in plasma collection and fractionation, Grifols is at the forefront of innovation in the blood plasma market.
- CSL Behring
CSL Behring is a leading global biotechnology company specializing in plasma-derived therapies. The company offers a wide range of products, including immunoglobulins, clotting factors, and albumin, to treat conditions such as hemophilia, immune deficiencies, and burn trauma.
- Shire (now part of Takeda)
Shire, now a part of Takeda, has a strong portfolio of plasma-derived therapies for rare diseases and hemophilia. The company's therapies have been used to treat bleeding disorders, immunodeficiencies, and other chronic conditions, making it a major player in the global market.
- Octapharma
Octapharma is another leading company in the blood plasma sector, offering high-quality immunoglobulin and albumin products. The company is expanding its footprint globally and has a strong focus on plasma collection and fractionation.
- Baxter International Inc.
Baxter International is a key player in the development of plasma-derived therapies for hemophilia and immunodeficiencies. The company’s portfolio includes immunoglobulins, clotting factors, and other plasma proteins, with a strong emphasis on patient-centric care.
Conclusion
The blood plasma Market is set to experience rapid growth in the coming years due to the increasing demand for plasma-derived therapies, the growing prevalence of chronic diseases, and significant advancements in medical treatments. As the global healthcare landscape evolves, plasma-based products will continue to play a critical role in treating a variety of life-threatening conditions. Companies are focusing on expanding their plasma collection infrastructure and improving the accessibility of plasma-derived therapies worldwide.
More Trending Latest Reports By Polaris Market Research:
Infectious Disease Diagnostics Market
Car Camera Cleaning Systems Market
Oyster and Clam Market
Recruitment Process Outsourcing Market
3D Printing Metals Market
Ultrasound Probe Cover Market: A Sanitized Approach to Staff Efficacy and Patient Safety
Rigid Plastic Packaging Market
Food Amino Acids Market
Cell Therapy Market